Pharmaceutical compositions consisting or consisting essentially

Details Pharmaceutical compositions consisting or consisting essentially Pharmaceutical compositions consisting or consisting essentially

1986-10-22

1988-05-24

Brown, J. R.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Liposomes

424 79, 514 34, 514 36, A61K 910, A61K 3174, A61K 3170

Patent

active

047465166

ABSTRACT:
A method is disclosed for purifying non-homogeneous systems, known as liposomic suspensions, from non-entrapped drugs wherein said suspensions are treated with liquid or solid polymers of synthetic and organic nature having chemical functionality, which are used as ion-exchangers. The liquid or solid polymers are based on styrene, divinylbenzene, acrylic acid, methacrylic acid, and the like, normally known as ion-exchange resins, and may include carboxylic, phosphonic or sulphonic functions of different matrices. The ion-exchange resins may also include salified quaternary ammonium, primary, secondary and tertiary amminic or phosphinic functions or other functions with different matrices, including phenolformaldehyde, styrene-divinylbenzene, acrylates, methacrylates, hydrocarbons and condensation-resins. Treatment may also be carried out with polymers, copolymers, or mixtures thereof, not having any specific chemical function and which normally, but not exclusively, react according to Van der Waals' forces, commonly known as adsorbents. The invention also includes freeze-dried pharmaceutical compositions consisting or consisting essentially of lyophilic liposomes of drugs, such as doxorubicin hydrochloride, aminosidine sulphate or 5-fluoro-uracil. The pharmaceutical compositions are characterized by a high degree of stability.

REFERENCES:
patent: 3398092 (1968-08-01), Fields
patent: 3794584 (1974-02-01), Kunin
patent: 3887698 (1975-06-01), McConnell
patent: 4016100 (1977-04-01), Suzuki
patent: 4131544 (1978-12-01), Elahi
patent: 4145304 (1979-03-01), Melnick
patent: 4229360 (1980-10-01), Schneider
patent: 4298594 (1981-11-01), Sears
Segal, Clin. Sci. & Mol. Med., 49:99-106, 1975.
Merck Index, 9th Ed., 1976, No. 3428.
Tritton, Biochem. & Biophys. Res. Comm., 84:802-808, 1978.
Tyrrell, Biochem. & Biophys., Acta 457:259-274, 1976.
F. J. T. Fildes (I.C.I), "Liposomes: From Physical Structure to Therapeutic Applications", 1981--475 to 477.
Juliano, R. L. et al., BBA, 770, 1984, 109 to 114.
Juliano, R. L. et al., Bio/Technology, Dec. 1983, 882 to 885.
Puisieux F., Labo-Pharma Probl. Tech., 30 (1982), No. 318, 133 to 151.
Weinstein, J. N. and Leserman, L. D., Pharmac. Ther., 24 (1984), 207 to 233.
Rao, L. S., "Liposomal Dosage Forms Development--Some Practical Considerations", J. Parent Sci. Tech., 37 (1983), No. 3, 72 to 75.
Weinstein, J. N., Cancer Treatment Reports, 68 (1984), 127 to 135.

Affiliated with

Also associated with

Rating

Pharmaceutical compositions consisting or consisting essentially does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions consisting or consisting essentially, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions consisting or consisting essentially will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1057544